Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 808

Results For "X"

9454 News Found

Scientific leaders signal major breakthroughs in elimination of cervical and anal cancers
Public Health | March 04, 2022

Scientific leaders signal major breakthroughs in elimination of cervical and anal cancers

To mark International HPV Awareness Day on March 4th 2022, the International Papillomavirus Society (IPVS) has warmly welcomed two major advances in the elimination of cervical and anal cancers


MIBCON NDC offers CO2 Optimisation module
Sustainability | March 04, 2022

MIBCON NDC offers CO2 Optimisation module

The CO2 Optimization module is one of the four modules (Product Costing, BoM Management, CO2 Optimization, Supplier Strategy) within the entire NDC Simulation Suite


Brinton ties up with Scholl Wellness Company
News | March 03, 2022

Brinton ties up with Scholl Wellness Company

Brinton Pharmaceuticals enters exclusive sales and distribution rights of Scholl foot care products including Krack cream


Merck KGaA reports higher profits on strong volumes across its businesses
News | March 03, 2022

Merck KGaA reports higher profits on strong volumes across its businesses

Company expects strong organic growth in sales, EBITDA in 2022


Alkem licenses technology from Harvard to treat ischemic injury and vascular diseases
Biotech | March 03, 2022

Alkem licenses technology from Harvard to treat ischemic injury and vascular diseases

Novel delivery of established growth and neurotrophic factors enables local, sustained release for greater efficacy


IIFL AMC funds acquire stake in OmniActive Health Technologies
Startup | March 03, 2022

IIFL AMC funds acquire stake in OmniActive Health Technologies

OmniActive seeks to improve lives by enhancing nutrition and wellness through science and innovation


Limited impact of short-term disruptions, growth momentum to continue in FY 23
News | March 03, 2022

Limited impact of short-term disruptions, growth momentum to continue in FY 23

Large players are adequately capitalised to make bigger investments to adjust for the ongoing fundamental shift in market opportunities


IHub-Data and IIIT-Hyderabad offer course on drug discovery
News | March 03, 2022

IHub-Data and IIIT-Hyderabad offer course on drug discovery

12-week certificate course commences on March 10th 2022


WHO includes molnupiravir in its Covid-19 treatment guidelines
Biotech | March 03, 2022

WHO includes molnupiravir in its Covid-19 treatment guidelines

This ninth update of WHO’s guideline on therapeutics includes a recommendation that casirivimab-imdevimab not be used for patients infected with the Omicron variant


Avenge Bio announces peer-reviewed publication on preclinical proof of concept for LOCOcyte platform technology
Biotech | March 03, 2022

Avenge Bio announces peer-reviewed publication on preclinical proof of concept for LOCOcyte platform technology

Ovarian cancer is one of the most difficult cancers to treat. It is typically not detected until later stages, and about 70 percent of patients will have recurrence after an initial treatment, which is often fatal